Morgan Stanley Expects Good Things from Walgreen Company 3QFY14 Earnings Report

In a report published Friday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating and $85.00 price target on

. In the report, Morgan Stanley noted, “We expect management to present a constructive message as it continues to work towards exercising step 2 of the AB deal and establishing the foundation for a ‘new Walgreens'. On the call we hosted with CEO & CFO last month management highlighted it is working with AB to form joined teams, analyzing structure of potential inversion, and articulated greater flexibility towards debt loads. We expect a similar message on earnings call to resonate well with investors.” Walgreen Company closed on Thursday at $75.39.